Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04391283
Brief Title: First Line Osimertinib for EGFR Mutation-positive Non-Small Cell Lung Cancer in Real World Chinese Setting

First Submitted : April 21, 2020
First Submitted that Met QC Criteria : May 15, 2020
First Posted : May 18, 2020

Last Update Submitted that Met QC Criteria : January 10, 2021
Last Update Posted : January 12, 2021